共有 1 页
品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|
罗恩 | R029850-10mg | 10mg | 现货 |
(3R,4R)-3-(5,6-二氢-4H-吡咯并[3,2... 3-(5,6-Dihydro-4H-pyrrolo[3,... |
99% |
|
|
罗恩 | R029850-50mg | 50mg | 5~7个工作日 |
(3R,4R)-3-(5,6-二氢-4H-吡咯并[3,2... 3-(5,6-Dihydro-4H-pyrrolo[3,... |
99% |
|
|
阿拉丁 | T127502-10mg | 10mg | 现货 |
替凡替尼 (ARQ 197) Tivantinib (ARQ 197) |
Moligand™, ≥98% |
|
|
阿拉丁 | T127502-50mg | 50mg | 现货 |
替凡替尼 (ARQ 197) Tivantinib (ARQ 197) |
Moligand™, ≥98% |
|
|
阿拉丁 | T127502-5mg | 5mg | 现货 |
替凡替尼 (ARQ 197) Tivantinib (ARQ 197) |
Moligand™, ≥98% |
|
|
阿拉丁 | T127502-25mg | 25mg | 现货 |
替凡替尼 (ARQ 197) Tivantinib (ARQ 197) |
Moligand™, ≥98% |
|
|
阿拉丁 | T127502-100mg | 100mg | 现货 |
替凡替尼 (ARQ 197) Tivantinib (ARQ 197) |
Moligand™, ≥98% |
|
|
阿拉丁 | T127502-250mg | 250mg | 现货 |
替凡替尼 (ARQ 197) Tivantinib (ARQ 197) |
Moligand™, ≥98% |
|
|
阿拉丁 | T426852-1ml | 1ml | 现货 |
Tivantinib (ARQ 197) Tivantinib (ARQ 197) |
Moligand™, 10mM in DMSO |
|
|
凯为 | JZ0037UO-5mg | 5mg | 期货,请咨询 |
(3R,4R)-3-(5,6-二氢-4H-吡咯并[3,2... (3R,4R)-3-(5,6-Dihydro-4H-py... |
99% |
|
|
凯为 | JZ0037UO-10mg | 10mg | 期货,请咨询 |
(3R,4R)-3-(5,6-二氢-4H-吡咯并[3,2... (3R,4R)-3-(5,6-Dihydro-4H-py... |
99% |
|
|
毕得 | BD224176-10mg | 10mg | 现货 |
(3R,4R)-3-(5,6-二氢-4H-吡咯并[3,2... (3R,4R)-3-(5,6-Dihydro-4H-py... |
99% |
|
|
毕得 | BD224176-5mg | 5mg | 现货 |
(3R,4R)-3-(5,6-二氢-4H-吡咯并[3,2... (3R,4R)-3-(5,6-Dihydro-4H-py... |
99% |
|
|
Matrix | MA143758-250mg | 250mg | 3-4周 |
(3R,4R)-3-(5,6-Dihydro-4H-py... (3R,4R)-3-(5,6-Dihydro-4H-py... |
95% | 咨询 | 请联系客服购买! |
Matrix | MA143758-1g | 1g | 3-4周 |
(3R,4R)-3-(5,6-Dihydro-4H-py... (3R,4R)-3-(5,6-Dihydro-4H-py... |
95% | 咨询 | 请联系客服购买! |
源叶 | S81087-2mg | 2mg | 现货 |
Tivantinib (ARQ 197) Tivantinib (ARQ 197) |
99% |
|
|
源叶 | S81087-5mg | 5mg | 现货 |
Tivantinib (ARQ 197) Tivantinib (ARQ 197) |
99% |
|
|
源叶 | S81087-10mg | 10mg | 现货 |
Tivantinib (ARQ 197) Tivantinib (ARQ 197) |
99% |
|
|
源叶 | S81087-50mg | 50mg | 现货 |
Tivantinib (ARQ 197) Tivantinib (ARQ 197) |
99% |
|
|
源叶 | S81087-100mg | 100mg | 期货,请咨询 |
Tivantinib (ARQ 197) Tivantinib (ARQ 197) |
99% |
|
|
源叶 | S81087-200mg | 200mg | 期货,请咨询 |
Tivantinib (ARQ 197) Tivantinib (ARQ 197) |
99% |
|
|
源叶 | T99845-1ml | 1ml | 期货,请咨询 |
Tivantinib (ARQ 197) Tivantinib (ARQ 197) |
10mM in DMSO |
|
|
Target Mol | T6117-1mg | 1mg | 现货 |
化合物 Tivantinib Tivantini |
99.41% |
|
|
Target Mol | T6117-5mg | 5mg | 现货 |
化合物 Tivantinib Tivantini |
99.41% |
|
|
Target Mol | T6117-10mg | 10mg | 现货 |
化合物 Tivantinib Tivantini |
99.41% |
|
|
Target Mol | T6117-25mg | 25mg | 现货 |
化合物 Tivantinib Tivantini |
99.41% |
|
|
Target Mol | T6117-50mg | 50mg | 现货 |
化合物 Tivantinib Tivantini |
99.41% |
|
|
Target Mol | T6117-100mg | 100mg | 现货 |
化合物 Tivantinib Tivantini |
99.41% |
|
|
Target Mol | T6117-200mg | 200mg | 现货 |
化合物 Tivantinib Tivantini |
99.41% |
|
|
Target Mol | T6117-1mL | 1mL | 现货 |
化合物 Tivantinib Tivantini |
99.41% |
|
|
Am | A891951-250mg | 250mg | 现货 |
Tivantinib Tivantini |
98% |
|
|
Am | A891951-100mg | 100mg | 现货 |
Tivantinib Tivantini |
98% |
|
|
Am | A891951-50mg | 50mg | 现货 |
Tivantinib Tivantini |
98% |
|
|
Am | A891951-5mg | 5mg | 现货 |
Tivantinib Tivantini |
98% |
|
|
Am | A891951-10mg | 10mg | 现货 |
Tivantinib Tivantini |
98% |
|
|
MCE | HY-50686-200mg | 200mg | 现货 |
Tivantinib Tivantini |
99.25% |
|
|
MCE | HY-50686-100mg | 100mg | 现货 |
Tivantinib Tivantini |
99.25% |
|
|
MCE | HY-50686-50mg | 50mg | 现货 |
Tivantinib Tivantini |
99.25% |
|
|
MCE | HY-50686-10mg | 10mg | 现货 |
Tivantinib Tivantini |
99.25% |
|
|
MCE | HY-50686-10mM*1mL | 10mM*1mL | 现货 |
Tivantinib Tivantini |
99.25% |
|
|
MCE | HY-50686-5mg | 5mg | 现货 |
Tivantinib Tivantini |
99.25% |
|
|